GGrantIndex
Sort

40,608 grants matching prostate cancer

Whole Genome Scan for Pancreatic Cancer Risk in the Pancreatic Cancer CohortCons

$1,314,335
Rachael Stolzenberg-Solomon · Division Of Cancer Epidemiology And Genetics · Z01 · FY2008 · CA

Mechanisms of Normal Tissue Toxicity

$1,312,449
Deborah Citrin · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA

TARGETING FZD6 SENSITIZES ADVANCED PROSTATE CANCER TO GENOTOXIC STRESS

$1,312,384
University Of Washington · · FY2022 · Defense Health Agency

Clinical Nursing and Data Management Core

$1,312,223
William Marston Linehan · Division Of Basic Sciences - Nci · ZID · FY2013 · CA

Prostate Cancer: Transition to Androgen-Independence

$1,312,107
Frank S French · Univ Of North Carolina Chapel Hill · P01 · FY2006 · CA

CONTINUOUS AHR ACTIVITY ACCELERATES PROSTATE CANCER PROGRESSION IN AFRICAN AMERICAN MEN

$1,311,656
Clark Atlanta University, Inc. · · FY2017 · Department of the Army

2/2 Cancer Research and Education to Advance HealTh Equity (CREATE) Partnership

$1,311,403
Maria Elena Martinez · University Of California, San Diego · U54 · FY2023 · CA

Somatic Mutations and Their Etiological Determinants for Breast Cancer in African American Women

$1,310,745
Song Yao · Roswell Park Cancer Institute Corp · R01 · FY2021 · CA

Nanotechnology Linking Biomarkers with Cancer Behavior

$1,309,745
Shuming Nie · Emory University · R01 · FY2008 · CA

Discovery Expansion and Replication

$1,308,677
Douglas Frederick Easton · Harvard School Of Public Health · U19 · FY2011 · CA

Prevention of Alzheimer's Diseae by Vitamin E and Selenium

$1,308,085
Frederick Schmitt · University Of Kentucky · R01 · FY2010 · AG

Animal Model and Genotyping Core Support Facility

$1,306,225
Wendy Du Bois · Division Of Basic Sciences - Nci · ZIC · FY2010 · CA

CLINICAL RESEARCH SITE: PROSTATE CANCER CLINICAL TRIALS (DF/HCC)

$1,306,217
Dana-Farber Cancer Institute, Inc. · · FY2009 · Department of Defense

VALIDATING CONDITIONALLY REPROGRAMMED CELLS TO ADVANCED PERSONALIZED MEDICINE FOR PROSTATE CANCER.

$1,306,200
Georgetown University · · FY2013 · Department of Defense

RACIAL DISPARITIES IN ACTIVE SURVEILLANCE ADHERENCE AND QUALITY OF LIFE IN A POPULATION-BASED PROSPECTIVE COHORT OF MEN WITH LOW-RISK PROSTATE CANCER...NEW GRANT, SIGNED 9/5/2019, EFFECTIVE 9/15/2019, DISTRIBUTED 9/6/2019, FAADC 9/10/2019

$1,305,085
Wayne State University · · FY2019 · Defense Health Agency

Prevention of Alzheimer's Diseae by Vitamin E and Selenium

$1,304,793
William R Markesbery · University Of Kentucky · R01 · FY2008 · AG

ROLE OF SRC-3DELTA4 IN THE PROGRESSION AND METASTASIS OF CASTRATION-RESISTANT PROSTATE CANCER

$1,304,350
Baylor College Of Medicine · · FY2011 · Department of the Army

Breast &Prostate Cancer &Hormone-Related Gene Variants

$1,303,157
Brigham And Women'S Hospital · U01 · FY2003 · CA

Targeting PTEN Null Tumors via Inhibition of the p110beta Isoform of PI3 Kinase

$1,302,860
Thomas M Roberts · Dana-Farber Cancer Inst · RC2 · FY2009 · CA

Somatic Mutations and Their Etiological Determinants for Breast Cancer in African American Women

$1,302,572
Song Yao · Roswell Park Cancer Institute Corp · R01 · FY2020 · CA

2/2 Cancer Research and Education to Advance HealTh Equity (CREATE) Partnership

$1,302,024
Maria Elena Martinez · University Of California, San Diego · U54 · FY2025 · CA

Prostate Cancer: Transition to Androgen-Independence

$1,301,427
Frank S French · Univ Of North Carolina Chapel Hill · P01 · FY2008 · CA

Leveraging DNA damage repair pathways as therapeutic targets in womens cancers

$1,301,281
Jung-Min Lee · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Targeting the Tumor Vasculature to Treat Cancer

$1,300,808
Steven K. Libutti · Division Of Clinical Sciences - Nci · Z01 · FY2008 · CA

Roswell Park Cancer Institute Center Support Grant

$1,300,294
Donald L Trump · Roswell Park Cancer Institute Corp · P30 · FY2009 · CA